131 related articles for article (PubMed ID: 20489042)
21. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
22. Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.
Dasarathy J; Alkhouri N; Dasarathy S
Liver Int; 2011 Oct; 31(9):1250-8. PubMed ID: 21745273
[TBL] [Abstract][Full Text] [Related]
23. Normalisation of insulin-like growth factor-I does not improve insulin action in cirrhosis.
Nielsen MF; Aagaard NK; Grøfte T; Frystyk J; Greisen J; Christiansen JS; Holland-Fischer P; Vilstrup H
Liver Int; 2011 Nov; 31(10):1511-8. PubMed ID: 21967317
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis.
Kaser S; Föger B; Waldenberger P; Nachbaur K; Propst A; Jaschke W; Vogel W; Patsch JR
J Hepatol; 2000 Dec; 33(6):902-6. PubMed ID: 11131451
[TBL] [Abstract][Full Text] [Related]
25. Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.
Montomoli J; Holland-Fischer P; Bianchi G; Grønbaek H; Vilstrup H; Marchesini G; Zoli M
World J Gastroenterol; 2010 Jan; 16(3):348-53. PubMed ID: 20082481
[TBL] [Abstract][Full Text] [Related]
26. Peripheral and hepatic insulin antagonism in hyperthyroidism.
Shen DC; Davidson MB; Kuo SW; Sheu WH
J Clin Endocrinol Metab; 1988 Mar; 66(3):565-9. PubMed ID: 3280588
[TBL] [Abstract][Full Text] [Related]
27. Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).
Raddatz D; Rossbach C; Buchwald A; Scholz KH; Ramadori G; Nolte W
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):268-74. PubMed ID: 15926112
[TBL] [Abstract][Full Text] [Related]
28. Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery.
de Weijer BA; Aarts E; Janssen IM; Berends FJ; van de Laar A; Kaasjager K; Ackermans MT; Fliers E; Serlie MJ
Obesity (Silver Spring); 2013 Jun; 21(6):1143-7. PubMed ID: 23913729
[TBL] [Abstract][Full Text] [Related]
29. Abnormal plasma peptide YY(3-36) levels in patients with liver cirrhosis.
Valentini L; Schuetz T; Omar A; Gläser S; Kasim E; Nowotny P; Kroencke T; Ockenga J
Nutrition; 2011 Sep; 27(9):880-4. PubMed ID: 21819934
[TBL] [Abstract][Full Text] [Related]
30. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
Koopmans SJ; Ohman L; Haywood JR; Mandarino LJ; DeFronzo RA
Diabetes; 1997 Oct; 46(10):1572-8. PubMed ID: 9313752
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the insulin resistance in liver cirrhosis: a comparison with non-insulin dependent diabetes mellitus.
Miyamoto I; Miyakoshi H; Nagai Y; Ohsawa K; Nishimura Y; Noto Y; Kobayashi K
Endocrinol Jpn; 1992 Oct; 39(5):421-9. PubMed ID: 1478183
[TBL] [Abstract][Full Text] [Related]
32. Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial.
Lee WG; Murphy R; McCall JL; Gane EJ; Soop M; Tura A; Plank LD
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667324
[TBL] [Abstract][Full Text] [Related]
33. Patients with psoriasis are insulin resistant.
Gyldenløve M; Storgaard H; Holst JJ; Vilsbøll T; Knop FK; Skov L
J Am Acad Dermatol; 2015 Apr; 72(4):599-605. PubMed ID: 25653028
[TBL] [Abstract][Full Text] [Related]
34. Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity.
Jimenez J; Zuniga-Guajardo S; Zinman B; Angel A
J Clin Endocrinol Metab; 1987 Apr; 64(4):661-8. PubMed ID: 3546350
[TBL] [Abstract][Full Text] [Related]
35. The mechanism of the carbohydrate intolerance of cirrhosis.
Proietto J; Alford FP; Dudley FJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1030-6. PubMed ID: 6999005
[TBL] [Abstract][Full Text] [Related]
36. Renal Denervation for Resistant Hypertension Fails to Improve Insulin Resistance as Assessed by Hyperinsulinemic-Euglycemic Step Clamp.
Miroslawska AK; Gjessing PF; Solbu MD; Fuskevåg OM; Jenssen TG; Steigen TK
Diabetes; 2016 Aug; 65(8):2164-8. PubMed ID: 27246911
[TBL] [Abstract][Full Text] [Related]
37. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations.
Nielsen MF; Caumo A; Aagaard NK; Chandramouli V; Schumann WC; Landau BR; Schmitz O; Vilstrup H
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1135-43. PubMed ID: 15637182
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance in human liver cirrhosis is not modified by porto-systemic surgical shunt.
Cavallo-Perin P; Bruno A; Nuccio P; Dall'omo AM; Fronda GR; Avagnina P; Molino G; Bozzo C; Pagano G
Acta Endocrinol (Copenh); 1986 Jul; 112(3):377-82. PubMed ID: 3529784
[TBL] [Abstract][Full Text] [Related]
39. Hyperinsulinemia in hepatic steatosis.
Oehler G; Bleyl H; Matthes KJ
Int J Obes; 1982; 6 Suppl 1():137-44. PubMed ID: 6749719
[TBL] [Abstract][Full Text] [Related]
40. Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism.
Plauth M; Schütz T; Buckendahl DP; Kreymann G; Pirlich M; Grüngreiff S; Romaniuk P; Ertl S; Weiss ML; Lochs H
J Hepatol; 2004 Feb; 40(2):228-33. PubMed ID: 14739092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
